Fast Market Research

IntelGenx Corp. - Product Pipeline Review - 2013: New Research Report Available at Fast Market Research

Recently published research from Global Markets Direct, "IntelGenx Corp. - Product Pipeline Review - 2013", is now available at Fast Market Research


Boston, MA -- (SBWIRE) -- 07/06/2013 -- Global Market Direct's pharmaceuticals report, "IntelGenx Corp. - Product Pipeline Review - 2013" provides data on the IntelGenx Corp.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, IntelGenx Corp.'s corporate website, SEC filings, investor presentations and featured press releases, both from IntelGenx Corp. and industry-specific third party sources, put together by Global Markets Direct's team.


- IntelGenx Corp. - Brief IntelGenx Corp. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of IntelGenx Corp. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of IntelGenx Corp. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the IntelGenx Corp.'s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

View Full Report Details and Table of Contents

Reasons to Get This Report

- Evaluate IntelGenx Corp.'s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of IntelGenx Corp. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the IntelGenx Corp.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with IntelGenx Corp..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of IntelGenx Corp. and identify potential opportunities in those areas.

About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- IntelGenx Corp. - Product Pipeline Review - 2012
- Anavex Life Sciences Corp. - Product Pipeline Review - 2013
- Inflammatory Pain - Pipeline Review, H1 2013
- Fibrosis - Pipeline Review, H1 2013
- Inflammatory Bowel Disease - Pipeline Review, H1 2013
- Bone Cancer - Pipeline Review, H1 2013
- Liver Fibrosis - Pipeline Review, H1 2013
- Sickle Cell Disease - Pipeline Review, H1 2013
- Diabetic Macular Edema - Pipeline Review, H1 2013
- Hypertension - Pipeline Review, H1 2013